Literature DB >> 9746206

Induction of programmed cell death in human retinoblastoma Y79 cells by C2-ceramide.

R Vento1, M Giuliano, M Lauricella, M Carabillò, D Di Liberto, G Tesoriere.   

Abstract

C2-ceramide, a cell-permeable analogue of ceramide, induced significant, dose- and time-dependent death in human retinoblastoma Y79 cells. Dying cells strongly displayed the morphology of apoptosis as characterized by microscopic evidence of cell shrinkage, membrane blebbing, nuclear and chromatin condensation and degeneration of the nucleus into membrane-bound apoptotic bodies. Upon induction of apoptosis Y79 cells evidence early phosphatidylserine externalization, as shown by annexin V-FITC. Apoptosis was also assessed by monitoring changes in cell granularity by staining with the combined fluorescent dyes acridine orange and ethidium bromide. C2-ceramide induced these morphological changes without a concomitant production of oligonucleosomal fragments responsible for the DNA ladder and without changes in p53 protein level. Apoptosis was accompanied by accumulation of a modified Bcl-2 protein with a slower-mobility form, and by proteolytic cleavage of PARP. The effect seemed to be specific for C2-ceramide, as C2-dihydroceramide, or other amphiphilic lipid analogues, or products of ceramide hydrolysis were ineffective. The effect also depended on mRNA and protein synthesis as it was markedly inhibited by actinomycin D and cycloheximide. Sphingomyelinase and interleukin-1beta, which are known to activate the sphingomyelin turnover leading to ceramide generation, also induced apoptosis mimicking the effects of ceramide. These findings propose ceramide as an activator of the suicidal program in Y79 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746206     DOI: 10.1023/a:1006836428202

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells.

Authors:  D J McConkey; D Goodrich; C Bucana; J Klostergaard
Journal:  Oncogene       Date:  1996-10-17       Impact factor: 9.867

2.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

Review 3.  Dicing with death: dissecting the components of the apoptosis machinery.

Authors:  S J Martin; D R Green; T G Cotter
Journal:  Trends Biochem Sci       Date:  1994-01       Impact factor: 13.807

4.  Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest.

Authors:  G S Dbaibo; M Y Pushkareva; S Jayadev; J K Schwarz; J M Horowitz; L M Obeid; Y A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

Authors:  M Y Kim; C Linardic; L Obeid; Y Hannun
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

6.  Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide.

Authors:  L R Ballou; C P Chao; M A Holness; S C Barker; R Raghow
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

7.  Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18).

Authors:  T J McDonnell; S J Korsmeyer
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

8.  Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells.

Authors:  M Giuliano; R Vento; M Lauricella; G Calvaruso; M Carabillo; G Tesoriere
Journal:  Eur J Biochem       Date:  1996-03-01

9.  Cell nucleus and DNA fragmentation are not required for apoptosis.

Authors:  K Schulze-Osthoff; H Walczak; W Dröge; P H Krammer
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

10.  Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons.

Authors:  P W Mesner; T R Winters; S H Green
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

View more
  5 in total

1.  S. choloroleuca, S. mirzayanii and S. santolinifolia protect PC12 cells from H(2)O (2)-induced apoptosis by blocking the intrinsic pathway.

Authors:  Shabnam Zeighamy Alamdary; Fariba Khodagholi; Fatemeh Shaerzadeh; Niloufar Ansari; Ali Sonboli; Solaleh Khoramian Tusi
Journal:  Cytotechnology       Date:  2011-12-31       Impact factor: 2.058

Review 2.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

3.  Commitment to apoptosis by ceramides depends on mitochondrial respiratory function, cytochrome c release and caspase-3 activation in Hep-G2 cells.

Authors:  Benoit Gentil; Fabrice Grimot; Catherine Riva
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

4.  Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.

Authors:  Hongbo Hu; Yubo Chai; Lei Wang; Jinhui Zhang; Hyo Jeong Lee; Sung-Hoon Kim; Junxuan Lü
Journal:  Mol Cancer Ther       Date:  2009-10       Impact factor: 6.261

5.  In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player.

Authors:  Riccardo Di Fiore; Rosa Drago-Ferrante; Antonella D'Anneo; Giuseppa Augello; Daniela Carlisi; Anna De Blasio; Michela Giuliano; Giovanni Tesoriere; Renza Vento
Journal:  Cancer Biol Ther       Date:  2013-08-12       Impact factor: 4.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.